Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVMD Revolution Medicines, Inc.

已收盘 01-08 16:00:00 EST

107.39

+4.68

+4.56%

盘后123.65

+16.26+15.14%

19:59 EST

最高112.43	最低94.52	成交量1,361万
今开95.21	昨收102.71	日振幅17.44%
总市值207.61亿	流通市值177.19亿	总股本1.93亿
成交额13.75亿	换手率8.25%	流通股本1.65亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVMD","market":"US","secType":"STK","nameCN":"Revolution Medicines, Inc.","latestPrice":107.39,"timestamp":1767906000000,"preClose":102.71,"halted":0,"volume":13607298,"hourTrading":{"tag":"盘后","latestPrice":123.65,"preClose":107.39,"latestTime":"19:59 EST","volume":1363346,"amount":163207267.939301,"timestamp":1767920398235},"delay":0,"floatShares":165000000,"shares":193319805,"eps":-5.193111,"marketStatus":"已收盘","change":4.68,"latestTime":"01-08 16:00:00 EST","open":95.21,"high":112.43,"low":94.5162,"amount":1374745929.26841,"amplitude":0.174411,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.193111,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1767949200000},"marketStatusCode":5,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":102.71,"preHourTrading":{"tag":"盘前","latestPrice":95.01,"preClose":102.71,"latestTime":"09:29 EST","volume":231785,"amount":22672137.8533,"timestamp":1767882599500},"postHourTrading":{"tag":"盘后","latestPrice":123.65,"preClose":107.39,"latestTime":"19:59 EST","volume":1363346,"amount":163207267.939301,"timestamp":1767920398235},"volumeRatio":3.012317,"impliedVol":0.67,"impliedVolPercentile":0.92},"requestUrl":"/m/hq/s/RVMD","defaultTab":"news","newsList":[{"id":"2602831784","title":"美股异动｜Revolution Medicines夜盘涨超13%，传获默沙东以至多320亿美元报价洽购","url":"https://stock-news.laohu8.com/highlight/detail?id=2602831784","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602831784?lang=zh_cn&edition=full","pubTime":"2026-01-09 09:22","pubTimestamp":1767921721,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1571399168.USD","LU0234572021.USD","LU0965509010.AUD","LU2468319806.SGD","LU2361045086.USD","SG9999001440.SGD","BK4533","LU1929549753.HKD","LU2360032135.SGD","SG9999014542.SGD","SG9999001176.USD","LU1023059063.AUD","LU1201861249.SGD","SG9999002224.SGD","LU1093756325.SGD","BK4516","LU0130517989.USD","LU0130102774.USD","LU1974910355.USD","LU0477156953.USD","LU1989772840.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU1989772923.USD","LU2125154778.USD","LU2361044949.HKD","LU1989771016.USD","LU0965508806.USD","LU1093756168.USD","MRK","IE000M9KFDE8.USD","LU0058720904.USD","SGXZ57979304.SGD","LU1057294990.SGD","LU1934455863.HKD","LU0861579265.USD","BK4007","LU1066051498.USD","LU1037948897.HKD","IE00BLSP4239.USD","LU1066053197.SGD","LU2125154935.USD","RVMD","LU1066051811.HKD","LU0006306889.USD","LU0648001328.SGD","LU0980610538.SGD","LU2361044865.SGD","LU0070302665.USD","LU0208291251.USD"],"gpt_icon":0},{"id":"1118901865","title":"美股夜盘 | OPEN涨近15%， 英特尔涨近2%；RVMD涨超15%，据报默沙东正就洽谈收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1118901865","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118901865?lang=zh_cn&edition=full","pubTime":"2026-01-09 09:00","pubTimestamp":1767920401,"startTime":"0","endTime":"0","summary":"1月9日，美股夜盘时段，$英特尔(INTC)$涨近2%，特朗普称与英特尔CEO进行了“不错的会面”。$Revolution Medicines(RVMD)$涨超15%，$默沙东(MRK)$据悉正洽购抗癌药开发商$Revolution Medicines(RVMD)$，交易价格或超300亿美元。美股在线房屋交易平台$Opendoor(OPEN)$涨近15%，特朗普宣布通过“两房”购买2000亿美元抵押贷款债券。$通用汽车(GM)$跌超1%，四季度因裁减电动汽车业务而计提60亿美元，非电动汽车相关计提大约11亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","INTC","OPEN"],"gpt_icon":0},{"id":"2602732316","title":"默沙东据悉洽购抗癌药开发商Revolution Medicines，交易价格或超300亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602732316","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602732316?lang=zh_cn&edition=full","pubTime":"2026-01-09 07:09","pubTimestamp":1767913740,"startTime":"0","endTime":"0","summary":"据知情人士称，美国制药巨头默沙东正就收购抗癌药物开发商Revolution Medicines进行谈判，交易金额为可能在280亿至320亿美元之间。　　受此消息推动，Revolution的股价在盘后交易中上涨了近16%。　　知情人士称，默沙东一直在寻求收购Revolution Medicines，但交易尚未敲定，并补充称，达成交易至少需要数周时间。　　瑞穗分析师估计，到2035年，Revolution的RAS抑制剂产品组合在全球的潜在销售额将超过100亿美元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-09/doc-inhfrztx3219551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1585245621.USD","LU1069347547.HKD","LU2361044949.HKD","LU1974910355.USD","IE0009355771.USD","LU0965509283.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0861579265.USD","LU1201861249.SGD","SG9999014567.USD","BK4533","LU1037948541.HKD","IE00BLSP4452.SGD","LU2324357040.USD","LU0477156953.USD","LU2023250843.SGD","LU0238689110.USD","LU1934455194.USD","LU1037948897.HKD","LU0265550359.USD","LU1929549753.HKD","LU1699723380.USD","IE0002141913.USD","LU2361045086.USD","SG9999001440.SGD","LU0070302665.USD","LU1116320737.USD","IE00BLSP4239.USD","LU0965509010.AUD","LU0965508806.USD","IE00B1BXHZ80.USD","LU1989772840.SGD","LU1066051811.HKD","LU2089984988.USD","LU0203347892.USD","BK4585","LU2023250504.SGD","LU0203345920.USD","LU1066053197.SGD","LU2125154935.USD","LU2112291526.USD","LU2361044865.SGD","LU1035773651.USD","LU0234572021.USD","LU0122379950.USD","LU0320765646.SGD","LU0648001328.SGD","LU0208291251.USD","LU2461242641.AUD","IE000M9KFDE8.USD","LU0106261372.USD","LU0058720904.USD","IE00BSNM7G36.USD","LU0130102774.USD","LU1430594728.SGD","LU1917777945.USD","BK4534","IE00B2B36J28.USD","BK4559","IE00BJJMRZ35.SGD","LU1571399168.USD","LU2468319806.SGD","LU1934455863.HKD","IE00B4R5TH58.HKD","LU0266013472.USD","SG9999001176.SGD","LU1066051225.USD","LU1162221912.USD","LU0130517989.USD","LU0098860793.USD","LU1291159041.SGD","BK4516","LU0211331839.USD","LU0289739699.SGD","SG9999015358.SGD","MRK","LU1941712264.USD","IE00BFTCPJ56.SGD","SG9999001176.USD","RVMD","LU2125154778.USD","BK4550","SG9999013999.USD","LU1061106388.HKD","LU1983299246.USD","LU1989772923.USD","SG9999002224.SGD","LU0320765489.SGD","SG9999015341.SGD","LU1941712348.USD","SG9999014542.SGD","LU2360032135.SGD","LU0985320562.USD","LU1989771016.USD","IE00BBT3K403.USD","LU0980610538.SGD","SG9999014575.USD","BK4007","LU1093756168.USD","BK4588","LU0965509101.SGD","IE00BN8TJ469.HKD","LU2106854487.HKD","LU0006306889.USD","BK4139","LU1116320901.HKD","SG9999014559.SGD","SGXZ57979304.SGD","LU1093756325.SGD","SG9999002232.USD","LU1934455277.USD","LU1066051498.USD","LU0265550946.USD","LU1023059063.AUD"],"gpt_icon":0},{"id":"1165108980","title":"Revolution Medicines股价盘后飙升18%逼近127美元 此前常规交易时段因并购传闻上涨4.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165108980","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165108980?lang=zh_cn&edition=full","pubTime":"2026-01-09 05:38","pubTimestamp":1767908314,"startTime":"0","endTime":"0","summary":"在传出并购相关消息后，Revolution Medicines, Inc.  股价呈现强劲双线拉升态势。常规交易时段该股收涨4.6%，而盘后交易时段更是一路冲高，涨幅达到18%，股价徘徊在127美元关口附近。从技术面看，股价在常规交易时段突破关键阻力位后，盘后量价齐升的走势进一步强化了多头格局。值得关注的是，该股近期波动率显著放大，昨日收盘价与盘后高点形成的价格缺口，可能成为后续走势的重要技术参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2601352484","title":"美股异动｜癌症药物开发商Revolution Medicines盘前跌9%，此前艾伯维否认收购传闻","url":"https://stock-news.laohu8.com/highlight/detail?id=2601352484","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601352484?lang=zh_cn&edition=full","pubTime":"2026-01-08 17:27","pubTimestamp":1767864453,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2601363653","title":"艾伯维否认洽购癌症药物开发商Revolution Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2601363653","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601363653?lang=zh_cn&edition=full","pubTime":"2026-01-08 10:15","pubTimestamp":1767838502,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2595779767","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 临近午盘大幅跳水5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595779767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595779767?lang=zh_cn&edition=full","pubTime":"2025-12-31 00:34","pubTimestamp":1767112441,"startTime":"0","endTime":"0","summary":"北京时间2025年12月31日00时34分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速下跌5.22%。截至发稿，该股报0.872美元/股，成交量2224股，换手率0.00%，振幅5.22%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.85%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231003402a6e20c86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231003402a6e20c86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","BK4139","RVMD"],"gpt_icon":0},{"id":"2594424505","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌6.26%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594424505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594424505?lang=zh_cn&edition=full","pubTime":"2025-12-27 02:11","pubTimestamp":1766772672,"startTime":"0","endTime":"0","summary":"北京时间2025年12月27日02时11分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价急速跳水6.26%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.35%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227021112a47c8c3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227021112a47c8c3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMDW","RVMD"],"gpt_icon":0},{"id":"2592575161","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫23.27% 市值跌2922.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592575161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592575161?lang=zh_cn&edition=full","pubTime":"2025-12-19 01:40","pubTimestamp":1766079654,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日01时40分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速跳水23.27%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.44%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219014055a6b38498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219014055a6b38498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","RVMDW","BK4139"],"gpt_icon":0},{"id":"1168747505","title":"Revolution Medicines宣布Rasolute 304临床试验中第一位随机患者的入组，该试验针对在辅助化疗后可切除胰腺导管腺癌使用Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=1168747505","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168747505?lang=zh_cn&edition=full","pubTime":"2025-12-18 21:03","pubTimestamp":1766062992,"startTime":"0","endTime":"0","summary":"Revolution Medicines宣布Rasolute 304临床试验中第一位随机患者的入组，该试验针对在辅助化疗后可切除胰腺导管腺癌使用Daraxonrasib","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2586544035","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘大幅拉升7.09%报0.600美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586544035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586544035?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:30","pubTimestamp":1763994628,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时30分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价快速上涨7.09%。截至发稿，该股报0.600美元/股，成交量1022股，换手率0.00%，振幅0.00%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.00%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223029a4b75243&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223029a4b75243&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2581963850","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘大幅拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581963850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581963850?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:43","pubTimestamp":1762526605,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日22时43分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速上涨5.26%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.61%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722432594f5ed10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722432594f5ed10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD","RVMDW"],"gpt_icon":0},{"id":"1162551616","title":"Revolution Medicines第三季度每股收益为-1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162551616","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162551616?lang=zh_cn&edition=full","pubTime":"2025-11-06 05:19","pubTimestamp":1762377577,"startTime":"0","endTime":"0","summary":"11月5日 - Revolution Medicines第三季度税前利润为-3.05206亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RVMD"],"gpt_icon":0},{"id":"2580103204","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 急速上涨7.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580103204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580103204?lang=zh_cn&edition=full","pubTime":"2025-11-04 00:48","pubTimestamp":1762188483,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日00时48分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价快速拉升7.11%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为1.38%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104004803a4859ae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104004803a4859ae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","RVMDW","BK4139"],"gpt_icon":0},{"id":"2576096134","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫15.38% 市值涨2225.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576096134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576096134?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:00","pubTimestamp":1760709629,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日22时00分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价大幅下挫15.38%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.28%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101722002994cf46ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101722002994cf46ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"1151488115","title":"FDA：预计在未来几个月内公布另一批专员国家优先券的接受者","url":"https://stock-news.laohu8.com/highlight/detail?id=1151488115","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151488115?lang=zh_cn&edition=full","pubTime":"2025-10-17 05:23","pubTimestamp":1760649791,"startTime":"0","endTime":"0","summary":"FDA：预计在未来几个月内公布另一批专员国家优先券的接受者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACHV","LU0823434583.USD","LU2023250504.SGD","BK4139","LU0058720904.USD","LU2362541513.USD","LU0823434740.USD","BK4585","LU2362540622.SGD","LU1974910355.USD","LU0320765992.SGD","REGN","LU0053666078.USD","LU2089984988.USD","LU2106854487.HKD","RVMD","LU2468319806.SGD","LU2362541273.HKD","LU0289739699.SGD","LU0823416689.USD","LU1917777945.USD","LU0109394709.USD","LU0882574055.USD","BK4588","LU0114720955.EUR","LU0889565916.HKD","LU2237438978.USD","IRON"],"gpt_icon":0},{"id":"2573626922","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大涨7.31%报0.320美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573626922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573626922?lang=zh_cn&edition=full","pubTime":"2025-10-08 22:05","pubTimestamp":1759932323,"startTime":"0","endTime":"0","summary":"北京时间2025年10月08日22时05分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价快速拉升7.31%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.25%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008220524a6b0d572&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008220524a6b0d572&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","BK4139","RVMD"],"gpt_icon":0},{"id":"2572570583","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572570583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572570583?lang=zh_cn&edition=full","pubTime":"2025-10-03 00:47","pubTimestamp":1759423637,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日00时47分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价快速下跌6.90%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.54%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003004717971d7585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003004717971d7585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2571366613","title":"Revolution Medicines, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571366613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571366613?lang=zh_cn&edition=full","pubTime":"2025-09-29 23:55","pubTimestamp":1759161319,"startTime":"0","endTime":"0","summary":"北京时间2025年09月29日23时55分，Revolution Medicines, Inc.股票出现波动，股价快速拉升5.01%。Revolution Medicines, Inc.股票所在的生物技术行业中，整体涨幅为1.54%。Revolution Medicines, Inc.公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929235519a6a6a271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929235519a6a6a271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD"],"gpt_icon":0},{"id":"1167803578","title":"Revolution Medicines宣布重要领导层人事任命，Alan Sandler医学博士出任首席开发官","url":"https://stock-news.laohu8.com/highlight/detail?id=1167803578","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167803578?lang=zh_cn&edition=full","pubTime":"2025-09-29 21:03","pubTimestamp":1759150996,"startTime":"0","endTime":"0","summary":"Revolution Medicines宣布重要领导层人事任命，Alan Sandler医学博士出任首席开发官","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RVMD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revmed.com","stockEarnings":[{"period":"1week","weight":0.2895},{"period":"1month","weight":0.2829},{"period":"3month","weight":1.1571},{"period":"6month","weight":1.7015},{"period":"1year","weight":1.3169},{"period":"ytd","weight":0.2895}],"compareEarnings":[{"period":"1week","weight":0.0112},{"period":"1month","weight":0.0087},{"period":"3month","weight":0.0274},{"period":"6month","weight":0.1058},{"period":"1year","weight":0.1715},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revolution Medicines, Inc.成立于2014年10月，是特拉华州的一家公司。该公司是一家临床阶段的精准肿瘤学公司，专注于开发靶向疗法，以抑制RAS成瘾癌症的前沿靶点。该公司拥有先进的基于结构的药物发现能力，其基础是深厚的化学生物学和癌症药理学知识以及创新的专有技术，能够创造适合非常规结合位点的小分子。该公司对癌症的遗传驱动因素和适应性耐药机制的了解，加上强大的药物发现和药物化学能力，指导建立了一个针对RAS通路和相关通路中的关键信号节点的深层管道。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.046835},{"month":2,"riseRate":0.6,"avgChangeRate":-0.005035},{"month":3,"riseRate":0.5,"avgChangeRate":-0.029333},{"month":4,"riseRate":0.666667,"avgChangeRate":0.052764},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.03349},{"month":6,"riseRate":0.833333,"avgChangeRate":0.042659},{"month":7,"riseRate":0.5,"avgChangeRate":-0.000709},{"month":8,"riseRate":0.666667,"avgChangeRate":0.059948},{"month":9,"riseRate":0.5,"avgChangeRate":0.038151},{"month":10,"riseRate":0.666667,"avgChangeRate":0.019949},{"month":11,"riseRate":0.833333,"avgChangeRate":0.188424},{"month":12,"riseRate":0.5,"avgChangeRate":-0.027192}],"exchange":"NASDAQ","name":"Revolution Medicines, Inc.","nameEN":"Revolution Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revolution Medicines, Inc.,RVMD,Revolution Medicines, Inc.股票,Revolution Medicines, Inc.股票老虎,Revolution Medicines, Inc.股票老虎国际,Revolution Medicines, Inc.行情,Revolution Medicines, Inc.股票行情,Revolution Medicines, Inc.股价,Revolution Medicines, Inc.股市,Revolution Medicines, Inc.股票价格,Revolution Medicines, Inc.股票交易,Revolution Medicines, Inc.股票购买,Revolution Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}